The significance of hepatitis G virus/hepatitis C virus coinfection - A review of the literature;Die bedeutung einer koinfektion mit dem hepatitis-G-virus fur die chronische hepatitis C - Ein review der literatur

Zeitschrift fur Gastroenterologie

Volumn 36, Issue 1, 1998, Pages 41-53

  Rambusch, E G ^a   Wedemeyer, H ^a   Tillmann, H L ^a   Heringlake, S ^a   Manns, M P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Coinfections; GBV C virus; Hepatitis C virus; Hepatitis G virus; Interferon

Indexed keywords

ALPHA INTERFERON; AMINOTRANSFERASE;

BLOOD TRANSFUSION; CHRONIC HEPATITIS; CLINICAL TRIAL; COMORBIDITY; DIALYSIS; DISEASE COURSE; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HIGH RISK POPULATION; HUMAN; INTRAVENOUS DRUG ABUSE; LIVER TRANSPLANTATION; META ANALYSIS; RELAPSE; REVIEW; VIRUS TRANSMISSION;

FLAVIVIRIDAE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; PROGNOSIS;

EID: 0031935410     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Linnen J, Wages J, Zhang-Keck ZY et al. Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 1996; 271: 505-8
2. Simmons JN, Leary TP, Dawson GJ et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1: 564-9
3. Heringlake S, Osterkam S, Trautwein C et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 1996; 348: 1626-9
4. Heringlake S, Tillmann HL, Cordes-Temme P et al. GBV-C/GBV-C is not the major cause of autoimmune hepatitis. J Hepatol 1996; 25: 980-4
5. Masuko K. Mitsui Z. Iwano K et al. Infection with hepatitis GB virus in patients on maintenance hemodialysis. N Engl J Med 1996; 334 (23): 1485-90
6. Alter HJ, Nakatsuji Y, Melpolder J et al. The incidence of transfusion-associated Hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997: 336 (11): 747-54
7. Kallinowski B, Ahmadi R, Müller HM et al. Prävalenz des GB-CVirus bei deutschen Blutspendern und Dialysepatienten. Z Gastroenterol 1996; 35: 644
8. Stark K, Bienzle U, Hess G et al. Detection of the hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors. J Infect Dis 1996; 174: 1320-3
9. Moaven LD, Hyland CA, Young IF et al. Prevalence of hepatitis G virus in Queensland blood donors. Med J Aust 1996; 165: 369-71
10. Nakatsuji Y. Shih JW. Tanaka E et al. Prevalence and disease association of hepatitis G virus infection in Japan. J Viral Hepat 1996; 3: 307-16
11. Wang HL, Jim DY. Prevalence and genotype of hepatitis G virus in Chinese professional blood donors and hepatitis patients. J Infect Dis 175 (5): 1229-33
12. Yohikawa A. Fukuda S, Itoh K et al. Infection with hepatitis G virus and its strain variant, the GB agent (GBV-C). among blood donors in Japan. Transfusion 1997; 37: 657-63
13. Loiseau P. Mariotti M, Ravera N et al. Prevalence of hepatitis G virus RNA in french blood donors and their recipients. Transfusion 1997; 37: 645-50
14. Roth WK, Waschk D, Marx S et al. Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their recipients. Transfusion 1997; 37: 651-6
15. Schmidt B. Korn K. Fleckenstein B. Molecular evidence for transmission of hepatitis G virus by blood transfusion. Lancet 1996: 347: 909 (letter)
16. Tsai NC, Nizokami M, Mukaidc M et al. HCV genotype distribution and the prevalence of GBVC/GBV-C infection in chronic hepatitis C (CHC) patients in Hawaii. Hepatology 1996; 24 (suppl.) (4, Pt. 2): 269 A (abstract)
17. Wu RR, Mizokami M. Cao K et al. GB Virus C/Hepatitis G virus infection in southern China. J Infect Dis 1997; 175: 168-71
18. Rezeig M. Mizokami M, Ahdal M. Kessie G, Fahir B. High prevalence of GBV-C/Hepatitis G virus infection among saudi patients infected with hepatitis C virus. Hepatology 1996; 24 (Pt. 2): 556 A
19. Schlueter V, Schmolke S. Stark K et al. Reverse transcription-PCR detection of hepatitis G virus. J Clin Microbiol 1996; 34: 2660-4
20. Jarvis LM. Davidson F, Hanley JP et al. Infection with hepatitis G virus among recipients of plasma products. Lancet 1996; 348: 1352-5
21. Wu JC, Sheng WY, IIuang YA, Hwang SJ, Lee SD. Prevalence and risk factor analysis of GBV-C/HGV infection in prostitutes. J Med Virol 52 (1): 83-5
22. Bogard M, Lovet M, Kmalaodine T, Barbanel C. Determination of hepatitis G virus (GBV-C) in dialyzed patients: Prevalence and rate of coinfection with hepatitis C virus (HCV). Hepatology 1996; 24 (Pt. 2): 486 B (abstract)
23. Feucht HH. Zöllner B. Polywka S et al. Prevalence of hepatitis G viremia among healthy subjects, indiviuals with liver disease, and persons at risk for parenteral transmission. J Clin Microbiol 1997; 35: 767-8
24. Schreier E, Höhne M. Künkel U, Berg T, Hopf U. Hepatitis GBV-C sequences in patients infected with HCV contaminated anti-D immunoglobulin and among i. v. drug users in Germany. J Hepatol 1996; 25: 385-9
25. Goeser T, Seipp S. Wahl R et al. Clinical presentation of GBV-C virus infection in drug abusers with chronic hepatitis C. J Hcpatol 1997: 498-502
26. '28 Viazov S, Riffelmann M, Sarr S et al. Transmission of GBV-C/HGV from drug-addicted mothers to their babies. J Hepatol 1997; 27: 85-90
27. Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med 1996; 334 (3): 193-4
28. Alter MJ, Gallagher M, Morris TT et al. Acute NonA-E Hepatitis in the United States and the role of Hepatitis G virus infection. N Engl J Med 1997; 336 (11): 741-6
29. Saiz JC, Ampurdanes S. Olmedo E et al. Hepatitis G virus infection in chronic hepatitis C: Frequency, features and response to interferon therapy. J Ilepatol 1997: 26: 787-93
30. Brandhagen DJ. Poterucha JJ, Gross JB Jr. et al. Hepatitis G infection in patients undergoing interferon alpha treatment for chronic hepatitis C: Clinical characteristics and GBV-C RNA levels. Hepatology 1996: 24 (suppl.) (4, Pt. 4): 229 A (abstract)
31. Wartelle C. Gerolami V. Planella R et al. Prevalence and impact of hepatitis G virus (GBV-C) infection in patients with chronic hepatitis C. Hepatology 1996: 24 (suppl.) (4, Pt. 2): 589 A (abstract)
32. Belli LS. Ideo G, Sillini E, Hepatitis G virus in posttransplant hepatitis. N Engl J Med 1996; 335 (18): 1394-5
33. Berg T. Naumann U. Fukumoto T et al. GB virus C infection in patients with chronic hepatitis C virus (HCV) infection following liver transplantation. Transplantation 1996; 62: 711-4
34. Fried MW, Khudyakow YE. Smallwood GA et al. Hepatitis G virus co-infection in liver transplantation recipients with chronic hepatitis C and non-viral chronic liver disease. Hepatology 1997: 25 (5): 1271-5
35. Tillmann HL, Heringlake S. Trautwein C et al. Prevalence of GBV-C RNA and E2 antibodies in liver transplant recipients: E2 antibodies protect from GBV-C infection. J Hepatol 1997: 26 (suppl. 1): 69 (abstract)
36. Murthy BVR. Muerhoff AS, Desai SM et al. GB hepatitis agent in cadaver organ donors and their recipients. Transplantation 1997; 63 (3): 346-51
37. Wang JT. Tsai FC. Lee CZ et al. A prospective study of transfusion-transmitted GB Virus C infection: Similar frequency but different clinical presentation compared with Hepatitis C virus. Blood 1996; 88: 1881-6
38. Francesconi R, Giostra F, Ballardini G et al. Clinical implications GBV-C/HGV infection in patients »with HCV-related« chronic hepatitis. J Hepatol 1997; 26: 1165-72
39. Bogard M, Cavla JM. Barjonet G et al. Analysis of hepatitis G virus (GBV-C) status in correlation with HCV scrotype, ALT levels and mode of transmission. Hepatology 1996; 24 (Pt. 2): 486 A (abstract)
40. Pawlotsky JM. Roudot-Thoraval F. Pellerin M et al. GBV-C infection in HCV-infected patients: Epidemiological characteristics, influence on HCV infection and response to interferon alpha therapy. Hepatology 1996: 24 (suppl.) (4, Pt. 2): 227 A (abstract)
41. Sedghi-Vaziri A. Nainan OV. McHutchinson JG. Alter MJ. Hepatitis G virus (GBV-C) coinfection does not influence response to interferon in patients with chronic HCV infection. Hepatology 1996; 24 (4, Pt. 2): 229 A (abstract)
42. Tong CYW, Gilmore IT, Williams H, Toh CH. Hart CA. Hepatitis G virus coinfection and interferon response in patients with chronic hepatitis C infection. Hepatology 1996; 24 (suppl.) (4. Pt. 2): 589 A (abstract)
43. Benetti GP, Ramella G, Lazza M et al. GBV-C infection in patients affected with HCV chronic liver disease: Prevalence and eligibility to the interferon treatment. Hepatology 1996; 24 (suppl.) (4. Pt. 2): 483 A (abstract)
44. Colombatto P. Randone A. Civitico G et al. Hepatitis G virus RNA in the serum of patients with elevated gamma glutamyl transpeptidase and alkaline phosphatase: A specific liver disease. J Viral Hepat 1996: 3: 301-6
45. Bralet MR, Roudot-Thoraval F. Pawlotsky JM et al. Histopathological impact of hepatitis GB virus C (GBV-C) infection on C virus chronic hepatitis. Gastroenterol. 1997; 112: 188-92
46. Berg T, Dirla U, Naumann U et al. Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus. J Hepatol 1996; 25: 763-8
47. Berenguer M, Terrault NA. Piatak M et al. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterol 1996; 111: 1569-75
48. Cotler SJ. Gretch DR, Bronner M et al. Hepatitis G Virus co-infection does not alter the course of recurrent hepatitis C virus infection in liver transplantation recipients. Hepatology 1997: 26: 432-6
49. Calleri G, Monti Gorin J, Macor A et al. Outcome of viral infections and disease in acute hepatitis C patients with or without hepatitis G virus coinfection. J Hepatol 1996; 25 (suppl. 1): 83 (abstract)
50. Reid AE, Koziel MJ, Aliza I et al. Hepatitis C virus genotypes and viremia, hepatitis G virus co-infection, and hepatocellular carcinoma. Hepatology 1996; 25 (suppl.) (4, Pt. 2): 347 A (abstract)
51. Müller C, Pfeffel F, Peck-Radosavljevic M et al. Hepatitis-G-Virus-Infektionen bei Patienten mit hepatozellulärem Karzinom. Z Gastroenterol 1996; 35: 727
52. Kubo S. Nishiguchi S. Kuroki T et al. Poor association of GBV-C viremia with hepatocellular carcinoma. J Hepatol 1997: 27: 91-5
53. Oshita M, Mita E, Ilo S et al. Hepatitis G virus infection in patients with chronic hepatitis C. Hepatology 1996; 24 (suppl.) (4, Pt. 2): 227 A (abstract)
54. Tanaka E. Alter HJ, Nakatsuji Y et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med 1996: 125: 740-3
55. Segawa T, Moriyama M. Miyauchi I et al. Effect of interferon treatment in GBV-C and HCV coinfected patients with chronic active hepatitis. Hepatology 1996; 24 (suppl.) (4, Pt. 2): 576 A (abstract)
56. Quian KP. Davis CL. Detmer J et al. Effect of interferon-(alpha) (IFN) and ribavirin on serum GBV-CRNA levels in patients co-infected with hepatitis C and G virus. Hepatology 1996: 24 (suppl.) (4, Pt. 2): 394 A (abstract)
57. Lau JY. Quian K. Detmer J et al. Effect of interferon-alpha and ribavirin therapy on serum CB virus C/hepatitis G virus (GBV-C/HGV) RNA levels in patients chronically infected with hepatitis C virus and GBV-C/HGV. J Infect Dis 176: 421-6
58. Lopex-Alcoroeho JM. Millan A. Garcia-Trevijano ER et al. Detection hepatitis GB-virus type C RNA in serum and liver from children with chronic viral hepatitis B and C. Hepatology 1997: 25: 1258-60
59. Zachoval R. Nitschko H. Brocdl U et al. GBV-C coinferlion in chronic hepatitis B and C: Differential inhibition of viral replication by interferon-(alpha) treatment. Hepatology 1996; 24 (suppl.) (4, Pt. 2): 225 A (abstract)
60. Fischler B. Lara C. Chen M et al. Genetic evidence for mother to infant transmission of hepatitis G virus. J Infect Dis 1997; 176: 281-5
61. Persico T, Thiers V. Tuveri V et al. Detection of hepatitis G/GB-C viral RNA but not HCV RNA in different semen fractions of infected patients. J Hepatol 1996; 25 (suppl. 1): 77 (abstract)
62. Pilot-Matias TJ. Carrick RJ. Colemann PF et al. Expression of GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker. Virology 1996; 225: 719-25
63. Dille BJ. Surowy TK, Gutierrez RA et al. An ELISA for detection of antibodies to the E2 protein of GB Virus C. J Infect Dis 1997; 175: 458-61
64. Feucht HH. Zöllner B, Polywka S et al. Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients. Hepatology 1997; 26: 491-4
65. Seipp S, Wahl R. Selzer S et al. Prevalence of GBVC in human periphereal blood monocuclear cells of GBV-C infected and GBV-C/HCV coinfected patients. Hepatology 1996; 24 (suppl.) (4. Pt. 2): 288 A (abstract)
66. Pessoa MG, Terrault NA, Ferrell LD et al. Hepatitis G virus in patients with cryptogenic liver disease undergoing liver transplantation. Hepatology 1997; 25 (5): 1266-70
67. Baba T. Makino R, Shibata M, Harada E, Mitamura K. Interferon treatment for hepatitis G virus infection in patients with chronic hepatitis C. Nippon Rinsho 1997; 55: 625-30
68. Martinet M, Marcellin P, Boyer N et al. Influence of hepatitis G virus infection on the severety of liver disease and response on interferon-α in patients with chronic hepatitis C. Ann Intern Med 1997: 126: 874-81
69. Crippin JS, Huang KS, Wright TL et al. Efficacy of interferon alfa 2A Roferon® A in the treatment of hepatitis C and G following liver transplantation. A prospective, randomised study. Hepatology 1996; 24 (suppl.) (4, Pt. 2): 294 A (abstract)
70. Enomoto M. Nishiguchi S, Tanaka M et al. Effect of interferon alpha in patients with chronic HCV and GBV-C coinfection. Hepatology 1996; 24 (suppl.) (4, Pt. 2): 231 A (abstract)
71. Giostra F, Francesconi R, Ballardini A et al. Sequential study of GBV-C viremia in patients with GBV-C and HCV coinfection: Effect of interferon treatment. J Hcpatol 1996: 25 (suppl. 1): 77 (abstract)
72. Kinoshita T. Miyake K. Nakao H et al. Molecular investigation of GB virus C infection in hemophiliacs in Japan. J Infect Dis 1997: 175: 454-7
73. De Lumbullerie X, Charrel RN. Dusso B. Hepatitis GB Virus C in patients on hemodialysis. N Engl J Med 1996: 334 (23): 1549
74. Nitschko H, Frösner GG, Zachoval R et al. Prävalenzuntersuchungen des Hepatitisvirus GBV-C: Häufige Koinfektionen mit HCV als Hinweis auf einen parenteralen Übertragungsweg. Z Gastroenterol 1996; 34: 88
75. Orito E. Mizokami M, Nakano T et al. Quantitative changes of serum GB virus C/hepatitis C virus (HCV) RNA in japanese patients with HCV/GBV-C coinfection treated with interferon-alpha. Hepatology 1996; 24 (suppl.) (4, Pt. 4): 228 A
76. Salas E, Gonzalez Vilchez J. Rebollo J et al. Hepatitis G virus infection in patients with hepatitis C treated with interferon. Hepatology 1996; 24 (suppl.) (4, Pt. 2): 572 A (abstract)
77. Schleicher S, Chaves RL, Dehmer T et al. Indentification of GBV-C hepatitis G RNA in chronic hepatitis C patients. J Med Virol 1996; 50: 71-4
78. Sheng L. Soumillion K. Peerlinck K et. al. Hepatitis G virus in peripheral blood monocular cells in hemophiliacs. Hepatology 1996: 24 (suppl.) (4, Pt. 2): 416 A (abstract)
79. Silini E. Beili L. Alberti AB et al. GBV-C infection and liver transplantation: Virological and clinical course. J Hepatol 1995; 24 (suppl. 1): 62
80. Solforosi L, Manzini A, Candela M et al. Low prevalence of GBV-C/HGV infection in Italian patients with »Non A-E« chronic liver disease. J Hepatol 1996; 25 (suppl. 1): 78 (abstract)
81. Thiers V, Pol S. Berthelot P. Nalpas B, Brechet C. GBV-C (BG-C) and HCV coinfection in french intravenous drug users. Prevalence and histological impact. J Hepatol 1996; 25 (suppl. 1): 87 (abstract)
82. Thomas JF, Bartolome J, Carreno V. Hepatitis GB virus C (letter). N Engl J Med 1996: 335 (18): 1393
83. Yoshiba M. Inoue K, Sekiyama K. Hepatitis GB Virus C (letter). N Engl J Med 1996; 335 (18): 1392-3
84. Liou TC, Chang TT, Young KG et al. Detection of HCV-RNA in saliva, urine, seminal fluid, and ascites. J Med Virol 1992; 37: 197-202
85. Kao JH. Chen PJ, Lai MY et al. GB virus/hepatitis G virus infection in an area endemic for viral hepatitis, chronic liver disease, and liver cancer. Gastroenterology 1997; 12: 1265-70
86. Feucht HH, Zöllner B. Polywka S. Laufs R. Vertical transmission of hepatitis G. Lancet 1996; 347: 615
87. Schmidt B, Korn K, Fleckenstein B. Molecular evidence for transmission of hepatitis G virus by blood transfusion. Lancet 1996: 347: 909